Avidin-biotin-Dota-90Y | m-entrepreneurship.com

Product Name :
Avidin-biotin-Dota-90Y

Search keywords :
Biotin

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Positron-emission tomography enhancers

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori

Active Company_Name :
Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Abciximab supplier
Galiximab Formula
CD44 Antibody (YA801): CD44 Antibody (YA801) is a non-conjugated and Mouse origined monoclonal antibody about 82 kDa, targeting to CD44 (2H12). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts